AM22-59-O: (On-Demand) Low-Yield Platelets: An Effective Solution to Our Platelet Shortage? (Enduring)
AM22-59-O: (On-Demand) Low-Yield Platelets: An Effective Solution to Our Platelet Shortage? (Enduring) is organized by Association for the Advancement of Blood & Biotherapies (AABB).
Expiration Date: Dec 31, 2024
Description:
A national shortage of blood components, especially platelets, have resulted in the need for creative ways of meeting the platelet needs of patients. Low-yield platelets are apheresis-derived platelets that contain less than 3.0 x 1011 platelets, which is the minimum required for a “standard-dose” platelet according to Food and Drug Administration regulations. Low-yield platelets may range from 2.6 to 2.9 x 1011 platelets which is approximately 10-15% fewer than a standard apheresis unit. The goal of this education session is to discuss the overall impact of low-yield platelets on blood centers, donors and recipients.
All relevant financial relationships have been mitigated.
Learning Objectives:
• Summarize current Food and Drug Administration regulations on platelet products.
• Discuss current evidence for the safety and efficacy of low yield platelets in transfused patients.
• Discuss the impact of low yield platelets on overall platelet supply.
• Describe criteria for receiving low-yield platelet products and for billing.
